Natesto the first androgen nasal gel
The US Food and Drug Administration ( FDA ) has approved Natesto (testosterone), once CompleoTRT™, the primary and solely androgen nasal gel for replacement medical aid in adult males for conditions related to a deficiency or absence of endogenous androgen . Natesto is self-administered via a nasal applier thereby minimizing the chance of secondary exposure to androgen of girls or youngsters .